The Effectiveness of Intermittent Fasting, Caloric Restriction and Physical Activity On Metabolic Syndrome
NCT ID: NCT07181655
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
140 participants
INTERVENTIONAL
2025-04-01
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)
NCT06271200
Sympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle Interventions
NCT00163943
Exercise Training Effects on Metabolic Syndrome: Interactions With Medication
NCT03019796
Prospective Metabolic Indicator Study
NCT03588117
Metabolic Syndrome and Degenerate Meniscus Tears
NCT04837456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Modified Intermittent Fasting
Intervention program of modified Intermittent fasting (Intermittent fasting, caloric restriction and physical activity)
Modified Intermittent Fasting
Participants in Intervention group will follow a structured intermittent fasting protocol, specifically the 16:8 method, where they fast for 16 consecutive hours each day and restrict their eating to an 8-hour window. The fasting period can be personalized to suit individual schedules. During these fasting hours, participants must abstain from all foods and caloric drinks, but are encouraged to stay hydrated with non-caloric beverages and they will follow a structured, calorie-restricted diet, tailored to them, using a developed Food Frequency Questionnaire tool to select their daily calorie intake across sections to identify appropriate foods and beverages for patients with metabolic conditions. They will be prescribed to engage in at least 150 minutes per week of moderate intensity aerobic activities, such as brisk walking will be measured and evaluated using the mobile application of physical activity recommended by the Ministry of Health in Saudi Arabia.
Control group: No Intervention
A control group receiving standard care provided by hospital
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Modified Intermittent Fasting
Participants in Intervention group will follow a structured intermittent fasting protocol, specifically the 16:8 method, where they fast for 16 consecutive hours each day and restrict their eating to an 8-hour window. The fasting period can be personalized to suit individual schedules. During these fasting hours, participants must abstain from all foods and caloric drinks, but are encouraged to stay hydrated with non-caloric beverages and they will follow a structured, calorie-restricted diet, tailored to them, using a developed Food Frequency Questionnaire tool to select their daily calorie intake across sections to identify appropriate foods and beverages for patients with metabolic conditions. They will be prescribed to engage in at least 150 minutes per week of moderate intensity aerobic activities, such as brisk walking will be measured and evaluated using the mobile application of physical activity recommended by the Ministry of Health in Saudi Arabia.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elevated triglycerides.
* Low HDL cholesterol.
* Elevated blood pressure.
* Elevated fasting blood glucose.
Exclusion Criteria
* Diagnosis of cardiac failure or/and severe renal or liver diseases, cancer.
* Having had bariatric surgery.
* Physical or mental disability.
* Neurological or cognitive impairment.
* Participant with severely impaired vision, hearing, or speech.
* Following a special diet or having changed their dietary pattern within the previous 12 weeks of the study's start date.
* Use of insulin or sulphonamide derivative oral antidiabetic drugs.
* Conditions that will seriously affect weight management such as having had bariatric surgery.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Putra Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LAMIA SALEM A ALMAZID
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hazizi Abu Saad, PhD
Role: STUDY_DIRECTOR
Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Associate Professor Dr. Hazizi Abu Saad
Serdang, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UPM-PhD LALMAZID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.